Those presenting with secondary hypogonadism consequent to idiopathic hypogonadotropic hypogonadism and Kallmann syndrome can be effectively treated with FSH and LH or with pulsatile GnRH administration (92–94). This evidence concerns the gene BRD2 and hypogonadotropic hypogonadism.